Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

AZ says Brilinta hits the mark in new stroke trial

AZ says Brilinta hits the mark in new stroke trial

Drug met primary endpoint in phase 3 THALES trial. Almost four years after failing to outperform aspirin in preventing stroke in high-risk patients, AstraZeneca’s Brilinta has hit the mark

AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer

AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer Improved overall survival when compared to chemotherapy. AstraZeneca and Daiichi Sankyo say new Enhertu data in gastric cancer could be enough to file for approval, potentially adding another indication to its

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca. .

AZ’s Imfinzi scores orphan drug status in liver cancer

AZ’s Imfinzi scores orphan drug status in liver cancer AstraZeneca’s PD-L1 Imfinzi, and anti-CTLA4 antibody tremelimumab, have been granted orphan drug designations (ODD) in the US for liver cancer.

Integrating electronic health records into clinical trials

Integrating electronic health records into clinical trials At the Leveraging EHR for Clinical Research Now! event, leaders from academia, companies including Amgen and AstraZeneca and the US Food and Drug Administration sought to identify the factors that are

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...
Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...

Infographics